Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Young Age and Aggressive Treatment in Colon Cancer
Berian, Julia R. , Benson, Al B. , Nelson, Heidi

JAMA | August 11, 2015 | Volume: 314 | Issue: 6 | Pages: 613

10.1001/jama.2015.9379 | PMID 26262799 Get It

Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention
Eckman, Christopher B., Eckman, Elizabeth A.

Biochemical Society Transactions | August 11, 2015 | Volume: 33 | Issue: 5 | Pages: 1101-1105

10.1042/bst0331101 Get It

The accumulation of Aβ (amyloid β-protein) peptides in the brain is a pathological hallmark of all forms of AD (Alzheimer's disease) and reducing Aβ levels can prevent or reverse cognitive deficits in mouse models of the disease. Aβ is produced continuously and its concentration is determined in part by the activities ofseveral degradative enzymes, including NEP (neprilysin), IDE (insulin-degrading enzyme), ECE-1 (endothelinconverting enzyme 1) and ECE-2, and probably plasmin. Decreased activity of any of these enzymes due to genetic mutation, or age- or disease-related alterations in gene expression or proteolytic activity, may increase the risk for AD. Conversely, increased expression of these enzymes may confer a protective effect. Increasing Aβ degradation through gene therapy, transcriptional activation or even pharmacological activation of the Aβ-degrading enzymes represents a novel therapeutic strategy for the treatment of AD that is currently being evaluated in cell-culture and animal models. In this paper, we will review the roles of NEP, IDE, ECE and plasmin in determining endogenous Aβ concentration, highlighting recent results concerning the regulation of these enzymes and their potential as therapeutic targets.
Crystallographic and single-particle analyses of native- and nucleotide-bound forms of the cystic fibrosis transmembrane conductance regulator (CFTR) protein
Awayn, N.H., Rosenberg, Mark F., Kamis, Alhaji Bukar, Aleksandrov, Luba A., Riordan, J.R., Ford, Robert C.

Biochemical Society Transactions | August 11, 2015 | Volume: 33 | Issue: 5 | Pages: 996-999

10.1042/bst0330996 Get It

Cystic fibrosis, one of the major human inherited diseases, is caused by defects in the CFTR (cystic fibrosis transmembrane conductance regulator), a cell-membrane protein. CFTR acts as a chloride channel which can be opened by ATP. Low-resolution structural studies of purified recombinant human CFTR are described in the present paper. Localization of the C-terminal decahistidine tag in CFTR was achieved by Ni2+-nitriloacetate nanogold labelling, followed by electron microscopy and single-particle analysis. The presence of the gold label appears to improve the single-particle-alignment procedure. Projection structures of CFTR from two-dimensional crystals analysed by electron crystallography displayed two alternative conformational states in the presence of nucleotide and nanogold, but only one form of the protein was observed in the quiescent (nucleotide-free) state.
BIOCHEMICAL AND BIOPHYSICAL STUDY OF THE YEAST MITOCHONDRIAL PROCESSING PEPTIDASE
Gakh, Oleksandr , Kalousek, František, Spížek, J., Adamec, Jiří , Obšil, Tomáš , Amler, Evžen , Janata, Jiřı́

Biochemical Society Transactions | August 11, 2015 | Volume: 28 | Issue: 5 | Pages: A350-A350

10.1042/bst028a350c Get It

Effects of exonic FTDP-17 missense mutations on the phosphorylation of tau protein
Gibb, Graham, Connell, James W., Dayanandan, Rejith, Lovestonem, S, Anderton, Brian H., Hutton, M.

Biochemical Society Transactions | August 11, 2015 | Volume: 28 | Issue: 1 | Pages: A37-A37

10.1042/bst028a037b Get It

Genetic Dissection of the Dementias
Hardy, John , Hardy, John

Biochemical Society Transactions | August 11, 2015 | Volume: 28 | Issue: 1 | Pages: A15-A15

10.1042/bst028a015 Get It

Mammalian hyaluronan synthases and their functions
Itano, Naoki , Yoshida, Mamoru, Yamada, Yoichi , Lenas, Petros, Spicer, Andrew P., McDonald, John A., Kimata, Koji

Biochemical Society Transactions | August 11, 2015 | Volume: 27 | Issue: 1 | Pages: A10-A10

10.1042/bst027a010b Get It

COMPARTMENTALIZATION OF cAMP-PROTEIN KINASE A (PKA) SIGNALING BY ISOZYMES PDE-IV AND PDE-III IN RAT MESANGIAL CELLS
Douša, Thomas P., Chini, Claudio, Chini, Eduardo N. , Tsuboi, Yasushi, Grande, Jorge

Biochemical Society Transactions | August 11, 2015 | Volume: 24 | Issue: 4 | Pages: 580S-580S

10.1042/bst024580sa Get It

Very low density lipoprotein subtraction apolipoprotein composition
Coppack, Simon W., Kottke, Bruce A., MILES, JOHN M., Fisher, Rachel M. , MILES, JOHN M.

Biochemical Society Transactions | August 11, 2015 | Volume: 21 | Issue: 3 | Pages: 231S-231S

10.1042/bst021231s | PMID 8224388 Get It

A case of lymphoproliferative disorder of NK‐cells: aggressive immunophenotype but indolent behavior
Savage, Natasha M. , Salman, Huda , Morice, William G. , Shi, Min , Morice, William George , Salman, Huda

Clinical Case Reports | August 11, 2015 | Volume: 3 | Issue: 9 | Pages: 740-743

10.1002/ccr3.333 | PMID 26401278 Get It

Key Clinical MessageDistinguishing chronic lymphoproliferative disorder of NK‐cells from aggressive NK‐cell leukemia is critical because they have distinct clinical course and management. Immunophenotyping plays a key role in distinguishing these two entities, however, it could not be used as sole criteria and clinical/laboratory findings are equally important.